
Stanford Student Wins Fellowship to Engineer Her Own Cure
Diagnosed with facioscapulohumeral muscular dystrophy at age 13, bioengineering student Héloïse Hoffmann has secured an O'Shaughnessy Fellowship to advance a novel gene therapy. The Stanford researcher is now moving her project from the laboratory to animal models, aiming to neutralize the toxic protein responsible for the rare muscle disease.



























